Eastman Chemical Company (EMN) Q2 2025 earnings summary

Executive summary

• Q2 2025 was marked by significant macroeconomic and tariff-related challenges, with resilient specialty business earnings, stable price-cost in specialties, and strong Additives & Functional Products performance from mix improvement and stable end markets.

• Advanced Materials delivered solid results despite end-market headwinds, while the circular platform advanced with record methanolysis production and growing customer engagement, though tariffs delayed new product launches.

• The company prioritized cash generation, aggressive inventory management, and cost reductions to navigate uncertainty.

• Net earnings attributable to shareholders were $140 million in Q2 2025, down from $230 million in Q2 2024; diluted EPS was $1.20 versus $1.94 year-over-year.

• Cash provided by operating activities was $66 million for the first six months of 2025, a significant decrease from $351 million in the prior year period.

Financial highlights

• Q2 2025 sales revenue was $2,287M, down from $2,363M in Q2 2024; adjusted EBIT was $275M (down from $353M); adjusted EBIT margin declined to 12.0% from 14.9% year-over-year.

• Adjusted EPS was $1.60, compared to $2.15 in Q2 2024 and $1.91 in Q1 2025.

• Gross margin for Q2 2025 was 22%, down from 25% in Q2 2024.

• Expect FY25 operating cash flow of ~$1 billion and capital expenditures of ~$550M.

• Returned $145M to shareholders via dividends and share repurchases in Q2 2025.

Outlook and guidance

• Q3 2025 adjusted EPS projected around $1.25, with mid-single digit volume decline in specialties due to trade disputes and seasonality.

• Full-year 2025 faces a challenging macro environment with intensified customer caution and tariff uncertainty; full-year operating cash flow expected to be ~$1B.

• On track for ~$75M net cost reduction in 2025, expanding to $150M–$175M by 2026.

• Inventory reduction to create a $75M–$100M asset utilization headwind in H2 2025, with $50M in Q3.

• Methanolysis ramp is slower than anticipated for 2025, but demand and EBITDA growth are expected to accelerate in 2026 as new applications and customers ramp up.